Literature DB >> 25550560

Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapy.

Francesco Pasqualetti1, Guido Bocci2, Valentina Mey2, Valentina Menghini3, Sabrina Montrone3, Paola Cocuzza3, Patrizia Ferrazza3, Veronica Seccia4, Durim Delishaj3, Cinzia Orlandini5, Maria Grazia Fabrini3, Romano Danesi2.   

Abstract

BACKGROUND: Radiotherapy (RT) with or without chemotherapy (CT) plays an important role as exclusive treatment in patients with head and neck squamous cell cancer (HNSCC). Unfortunately, in some cases, benefit for patients is not recorded and only treatment-related complications are registered.
MATERIALS AND METHODS: Data relating to Akt1 single nucleotide polymorphism (SNP) and response to treatment of 46 patients treated with exclusive RT or RT-CT for HNSCC were evaluated.
RESULTS: For heterozygous patients median overall survival was 28.5 months, while for the wild-type group median overall survival was 10.9 (p=0.019). Three-year survival was 85% for mutated Akt1 homozygosis and 40% for patients with a heterozygous status (p=0.019, hazard ratio (HR)=7.960).
CONCLUSION: SNP of rs2498804 can recognize patients resistant to RT-CT. Further studies are needed to confirm our data and to investigate the role of Akt SNPs in HNSCC patients. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  AKT; chemotherapy; head neck; radiotherapy

Mesh:

Substances:

Year:  2015        PMID: 25550560

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy.

Authors:  Francesco Pasqualetti; Alessandra Gonnelli; Paola Orlandi; Eleonora Palladino; Noemi Giannini; Giovanni Gadducci; Roberto Mattioni; Sabrina Montrone; Elisa Calistri; Chiara Maria Mazzanti; Sara Franceschi; Valerio Ortenzi; Cristian Scatena; Katia Zavaglia; Giuseppe Nicolo Fanelli; Riccardo Morganti; Orazio Santonocito; Guido Bocci; Giuseppe Antonio Naccarato; Fabiola Paiar
Journal:  Invest New Drugs       Date:  2021-02-08       Impact factor: 3.850

2.  Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol.

Authors:  Durim Delishaj; Stefano Ursino; Francesco Pasqualetti; Fabrizio Matteucci; Agostino Cristaudo; Carlo Pietro Soatti; Amelia Barcellini; Fabiola Paiar
Journal:  Radiat Oncol J       Date:  2018-03-30

Review 3.  Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects.

Authors:  Simona Granata; Alessandra Dalla Gassa; Amedeo Carraro; Matteo Brunelli; Giovanni Stallone; Antonio Lupo; Gianluigi Zaza
Journal:  Int J Mol Sci       Date:  2016-05-14       Impact factor: 5.923

4.  Systematic understanding of anti-tumor mechanisms of Tamarixetin through network and experimental analyses.

Authors:  Sanu K Shaji; G Drishya; Damu Sunilkumar; Prashanth Suravajhala; Geetha B Kumar; Bipin G Nair
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.